Streetbeat News

Dividends

ABM

ABM Industries Incorporated (NYSE:ABM) is set to release its Q1 earnings on March 7, 2024, with analysts expecting a decrease in earnings per share from the previous year. The company recently announced a partnership with the Arizona Diamondbacks and Chase Field. ABM offers a dividend yield of 2.18%, equating to a quarterly dividend of 22.5 cents a share. To earn a monthly dividend income of $500, an investor would need to own approximately 6,667 shares, valued around $271,680. The article also explains how dividend yield can fluctuate with stock price and dividend payment changes. ABM's stock fell 1.2% to close at $40.75 recently.

Portfolio Pulse from Avi Kapoor

March 06, 2024 | 2:19 pm

GBLI

Global Indemnity Group, LLC (NYSE:GBLI) announced a 40% increase in its quarterly dividend from $0.25 to $0.35 per share, payable on March 28, 2024, to shareholders of record as of March 21, 2024. This increase reflects GBLI's strong financial performance, capital and reserve positions, liquidity, and balance sheet. Since going public, GBLI has repaid all debt and returned over $600 million to shareholders. Future dividends are subject to Board discretion based on financial health and other factors.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:46 pm

XTKG

X3 Holdings Co., Ltd. (NASDAQ:XTKG) announced a 6% common stock dividend to be distributed on May 27, 2024, to shareholders of record as of April 26, 2024. This move aims to boost shareholder value and liquidity, reflecting the company's commitment to its investors and confidence in future growth.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:41 pm

MEDS

TRxADE Health announced a special cash dividend of $8 per share, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:35 pm

CELZ

CRWD

MEDS

CrowdStrike Holdings (CRWD) shares surged 27% after reporting better-than-expected Q4 earnings and revenues, with positive guidance for Q1 and FY25, leading to raised price targets by analysts. Creative Medical Technology Holdings, Inc. (CELZ) saw an 85% increase after receiving FDA Orphan Drug Designation for CELZ-101. TRxADE Health, Inc. (MEDS) announced a special cash dividend of $8/share, resulting in a 67% stock price increase.

Portfolio Pulse from ryanfaloona@benzinga.com

March 06, 2024 | 1:33 pm

MEDS

TRxADE Health, Inc. has declared a special cash dividend of $8 per share, a significant return to its shareholders. This move could indicate strong financial health or a strategy to return excess cash to shareholders.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 1:06 pm

GTN

PLTK

SBGI

Wall Street's most accurate analysts have provided their views on three high-yielding tech and telecom stocks: Sinclair, Inc. (SBGI), Playtika Holding Corp. (PLTK), and Gray Television, Inc. (GTN). These stocks offer dividend yields above 5% and have received various ratings and price target adjustments based on recent financial performances and market outlooks.

Portfolio Pulse from Avi Kapoor

March 06, 2024 | 12:24 pm

BABA

JD

PGJ

RTH

JD.com, Inc. (NASDAQ: JD) reported a 3.6% year-on-year revenue growth for Q4 fiscal 2023, reaching $43.1 billion and surpassing the consensus of $42.2 billion. Its adjusted net income per ADS of $0.75 also beat the consensus of $0.63, leading to a stock price increase. The company announced a new buyback program worth up to $3.0 billion and an annual cash dividend of $0.76 per ADS. Investors can also gain exposure to JD.com through the Invesco Golden Dragon China ETF (NASDAQ: PGJ) and the VanEck Retail ETF (NASDAQ: RTH).

Portfolio Pulse from Anusuya Lahiri

March 06, 2024 | 11:44 am

SOHO

Sotherly Hotels provided its 2024 financial guidance, projecting total revenue between $178.952M and $182.567M, with an adjusted FFO per share of $0.64 to $0.69. The company anticipates a net income of $1.598M to $2.593M, but expects a net loss available to common stockholders and unitholders ranging from $6.377M to $5.382M. EBITDA is estimated to be between $39.858M and $40.853M, with Hotel EBITDA between $46.103M and $46.898M. The guidance also includes a Hotel EBITDA margin of 25.8% to 25.7%.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:37 am

JD

JD.Com's shares surged following the announcement of its Q4 financial results, which exceeded expectations. Additionally, the company announced a new stock buyback program and its first annual cash dividend, signaling confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:16 am